US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist

3.560
+0.020+0.56%

Close May 14 16:00 ET

3.640
+0.080+2.25%

Post 19:52 ET

194.51MMarket Cap-4188P/E (TTM)

Elevation Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

43.11%-9.58M

34.28%-56.18M

31.76%-12.18M

69.77%-13.36M

-46.50%-13.81M

-20.02%-16.83M

-183.37%-85.48M

-100.24%-17.85M

-459.00%-44.18M

-143.47%-9.43M

Net income from continuing operations

37.24%-10.71M

51.93%-45.7M

58.52%-7.9M

72.61%-10.64M

49.26%-10.11M

1.25%-17.06M

-196.76%-95.08M

-97.90%-19.04M

-216.60%-38.84M

-293.87%-19.93M

Operating gains losses

--942K

----

Depreciation and amortization

0.00%10K

44.44%39K

0.00%10K

12.50%9K

100.00%10K

150.00%10K

50.00%27K

100.00%10K

166.67%8K

-16.67%5K

Other non cash items

-2.42%161K

146.32%702K

10.78%185K

--180K

--172K

--165K

--285K

--167K

----

Change In working capital

51.91%-605K

-317.65%-13.69M

-1,380.84%-4.28M

43.76%-3.55M

-147.67%-4.61M

-148.25%-1.26M

2,122.61%6.29M

2,285.71%334K

-270.52%-6.31M

844.28%9.66M

-Change in prepaid assets

36.07%1.23M

-251.31%-2.14M

-215.89%-815K

-18.40%-2.74M

-48.95%512K

-6.15%901K

64.58%-610K

-348.08%-258K

-1.58%-2.32M

25.38%1M

-Change in payables and accrued expense

15.19%-1.83M

-267.35%-11.55M

-684.97%-3.46M

79.78%-808K

-159.11%-5.12M

-231.09%-2.16M

244.14%6.9M

757.78%592K

-166.82%-4M

3,782.06%8.66M

Cash from discontinued investing activities

Operating cash flow

43.11%-9.58M

34.28%-56.18M

31.76%-12.18M

69.77%-13.36M

-46.50%-13.81M

-20.02%-16.83M

-183.37%-85.48M

-100.24%-17.85M

-459.00%-44.18M

-143.47%-9.43M

Investing cash flow

Cash flow from continuing investing activities

-22.18%20.7M

126.00%11.54M

-41.33%6.56M

-385.18%-38.12M

59.79%16.5M

133.56%26.6M

-44.4M

11.18M

13.37M

10.33M

Net PPE purchase and sale

----

--0

----

---86K

--0

----

Net investment purchase and sale

-22.18%20.7M

126.05%11.54M

-41.33%6.56M

-383.36%-38.12M

59.79%16.5M

133.56%26.6M

---44.31M

--11.18M

--13.45M

--10.33M

Cash from discontinued investing activities

Investing cash flow

-22.18%20.7M

126.00%11.54M

-41.33%6.56M

-385.18%-38.12M

59.79%16.5M

133.56%26.6M

---44.4M

--11.18M

--13.37M

--10.33M

Financing cash flow

Cash flow from continuing financing activities

13,904.63%30.25M

62.55%47.98M

50.00%-2K

-99.91%27K

191,036.00%47.73M

1,036.84%216K

-69.59%29.51M

-4K

480.61%29.52M

-100.03%-25K

Net issuance payments of debt

----

--0

----

--30M

--0

----

Net common stock issuance

247,016.67%29.63M

132,897.14%46.48M

50.00%-2K

50.00%-3K

186,084.00%46.5M

---12K

-100.04%-35K

---4K

-100.12%-6K

---25K

Proceeds from stock option exercised by employees

237.72%770K

7,773.68%1.5M

--0

--30K

--1.24M

1,100.00%228K

--19K

--0

Net other financing activities

---150K

----

-4,172.73%-470K

--0

----

Cash from discontinued financing activities

Financing cash flow

13,904.63%30.25M

62.55%47.98M

50.00%-2K

-99.91%27K

191,036.00%47.73M

1,036.84%216K

-69.59%29.51M

---4K

480.61%29.52M

-100.03%-25K

Net cash flow

Beginning cash position

7.27%49.26M

-68.61%45.92M

4.35%54.88M

97.33%106.33M

5.46%55.9M

-68.61%45.92M

84.24%146.28M

-66.11%52.59M

-65.90%53.88M

-24.18%53.01M

Current changes in cash

314.37%41.38M

103.33%3.34M

15.72%-5.62M

-3,878.89%-51.45M

5,669.22%50.42M

110.70%9.99M

-250.06%-100.37M

25.15%-6.67M

54.13%-1.29M

-99.01%874K

End cash Position

62.12%90.63M

7.27%49.26M

4.35%54.88M

97.33%106.33M

5.46%55.9M

-68.61%45.92M

-66.11%52.59M

-65.90%53.88M

Free cash flow

43.11%-9.58M

34.35%-56.18M

31.76%-12.18M

69.83%-13.36M

-46.50%-13.81M

-20.02%-16.83M

-183.65%-85.57M

-100.24%-17.85M

-460.08%-44.27M

-143.47%-9.43M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	43.11%-9.58M	34.28%-56.18M	31.76%-12.18M	69.77%-13.36M	-46.50%-13.81M	-20.02%-16.83M	-183.37%-85.48M	-100.24%-17.85M	-459.00%-44.18M	-143.47%-9.43M
Net income from continuing operations	37.24%-10.71M	51.93%-45.7M	58.52%-7.9M	72.61%-10.64M	49.26%-10.11M	1.25%-17.06M	-196.76%-95.08M	-97.90%-19.04M	-216.60%-38.84M	-293.87%-19.93M
Operating gains losses	--942K	----	----	----	----	----	----	----	----	----
Depreciation and amortization	0.00%10K	44.44%39K	0.00%10K	12.50%9K	100.00%10K	150.00%10K	50.00%27K	100.00%10K	166.67%8K	-16.67%5K
Other non cash items	-2.42%161K	146.32%702K	10.78%185K	--180K	--172K	--165K	--285K	--167K	----	----
Change In working capital	51.91%-605K	-317.65%-13.69M	-1,380.84%-4.28M	43.76%-3.55M	-147.67%-4.61M	-148.25%-1.26M	2,122.61%6.29M	2,285.71%334K	-270.52%-6.31M	844.28%9.66M
-Change in prepaid assets	36.07%1.23M	-251.31%-2.14M	-215.89%-815K	-18.40%-2.74M	-48.95%512K	-6.15%901K	64.58%-610K	-348.08%-258K	-1.58%-2.32M	25.38%1M
-Change in payables and accrued expense	15.19%-1.83M	-267.35%-11.55M	-684.97%-3.46M	79.78%-808K	-159.11%-5.12M	-231.09%-2.16M	244.14%6.9M	757.78%592K	-166.82%-4M	3,782.06%8.66M
Cash from discontinued investing activities
Operating cash flow	43.11%-9.58M	34.28%-56.18M	31.76%-12.18M	69.77%-13.36M	-46.50%-13.81M	-20.02%-16.83M	-183.37%-85.48M	-100.24%-17.85M	-459.00%-44.18M	-143.47%-9.43M
Investing cash flow
Cash flow from continuing investing activities	-22.18%20.7M	126.00%11.54M	-41.33%6.56M	-385.18%-38.12M	59.79%16.5M	133.56%26.6M	-44.4M	11.18M	13.37M	10.33M
Net PPE purchase and sale	----	--0	--0	----	----	----	---86K	--0	----	----
Net investment purchase and sale	-22.18%20.7M	126.05%11.54M	-41.33%6.56M	-383.36%-38.12M	59.79%16.5M	133.56%26.6M	---44.31M	--11.18M	--13.45M	--10.33M
Cash from discontinued investing activities
Investing cash flow	-22.18%20.7M	126.00%11.54M	-41.33%6.56M	-385.18%-38.12M	59.79%16.5M	133.56%26.6M	---44.4M	--11.18M	--13.37M	--10.33M
Financing cash flow
Cash flow from continuing financing activities	13,904.63%30.25M	62.55%47.98M	50.00%-2K	-99.91%27K	191,036.00%47.73M	1,036.84%216K	-69.59%29.51M	-4K	480.61%29.52M	-100.03%-25K
Net issuance payments of debt	----	--0	--0	----	----	----	--30M	--0	----	----
Net common stock issuance	247,016.67%29.63M	132,897.14%46.48M	50.00%-2K	50.00%-3K	186,084.00%46.5M	---12K	-100.04%-35K	---4K	-100.12%-6K	---25K
Proceeds from stock option exercised by employees	237.72%770K	7,773.68%1.5M	--0	--30K	--1.24M	1,100.00%228K	--19K	--0	--0	--0
Net other financing activities	---150K	----	----	----	----	----	-4,172.73%-470K	--0	----	----
Cash from discontinued financing activities
Financing cash flow	13,904.63%30.25M	62.55%47.98M	50.00%-2K	-99.91%27K	191,036.00%47.73M	1,036.84%216K	-69.59%29.51M	---4K	480.61%29.52M	-100.03%-25K
Net cash flow
Beginning cash position	7.27%49.26M	-68.61%45.92M	4.35%54.88M	97.33%106.33M	5.46%55.9M	-68.61%45.92M	84.24%146.28M	-66.11%52.59M	-65.90%53.88M	-24.18%53.01M
Current changes in cash	314.37%41.38M	103.33%3.34M	15.72%-5.62M	-3,878.89%-51.45M	5,669.22%50.42M	110.70%9.99M	-250.06%-100.37M	25.15%-6.67M	54.13%-1.29M	-99.01%874K
End cash Position	62.12%90.63M	7.27%49.26M	7.27%49.26M	4.35%54.88M	97.33%106.33M	5.46%55.9M	-68.61%45.92M	-68.61%45.92M	-66.11%52.59M	-65.90%53.88M
Free cash flow	43.11%-9.58M	34.35%-56.18M	31.76%-12.18M	69.83%-13.36M	-46.50%-13.81M	-20.02%-16.83M	-183.65%-85.57M	-100.24%-17.85M	-460.08%-44.27M	-143.47%-9.43M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall